The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis Xuanwei Li, Wenlai Li, Yue Li, Chuanjiang Dong, Ping Zhu

Autosomal dominant polycystic kidney disease V. E. TORRES , P. C. HARRIS

CKD Staging-evolution not revolution Winearls, Haynes, Glassock